Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Clinical trial NCT01635803 · UNKNOWN
Trial details
- NCT number
- NCT01635803
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-06-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.